The latest announcement is out from Estrella Immunopharma (ESLA).
Estrella Immunopharma, Inc. has appointed Ms. Hong Zhang as the new Chairperson and member of the Board of Directors, expanding the board to six members. The CEO, Dr. Cheng Liu, will remain on the board while Ms. Zhang will be compensated for her roles and reimbursed for expenses. Estrella is also negotiating a Consulting Agreement with Ms. Zhang’s company for strategic initiatives in Asia. Details of the agreement are pending audit committee approval. The company’s press release about these changes is not considered filed for regulatory purposes but is provided for informational use.
See more data about ESLA stock on TipRanks’ Stock Analysis page.
